Clinic
Southern Immediate Care, LLC
Southern Immediate Care, LLC was paid $12.55M by Medicaid between Jan 2018 and Dec 2024, across 49 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 26% of everything it billed.
33Billing provider infoSOUTHERN IMMEDIATE CARE, LLC
ANNISTON, AL 36201
ANNISTON, AL 36201
33aNPI1467909978assigned 09/01/2016
33bProvider typeUrgent Care Clinic/Center
28Total paid$12.55M
24GClaims377,681
24DCodes billed49
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Alabama
Rank by total paid#1 of 59
Median peer was paid$77K
This provider vs. median163×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,109 | $256K | |
| 2019 | 19,638 | $513K | |
| 2020 | 21,230 | $859K | |
| 2021 | 71,833 | $1.79M | |
| 2022 | 78,445 | $2.79M | |
| 2023 | 112,932 | $3.73M | |
| 2024incomplete | 62,494 | $2.60M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 26% | 55,795 | 45,275 | $3.31M |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 16% | 21,741 | 16,789 | $2.05M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 8.7% | 13,859 | 10,713 | $1.10M |
| 87631 | 7.8% | 16,779 | 14,841 | $977K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.7% | 17,594 | 14,152 | $712K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 5.2% | 17,274 | 12,425 | $656K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4.5% | 10,875 | 8,550 | $569K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 3.8% | 3,158 | 2,512 | $478K |
| 87486 | 3.4% | 18,620 | 15,720 | $423K | |
| 87581 | 3.4% | 18,616 | 15,720 | $423K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.1% | 44,387 | 19,325 | $385K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.6% | 8,063 | 7,597 | $328K |
37 more codes
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.4% | 30,221 | $305K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.9% | 30,493 | $232K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.4% | 14,351 | $170K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 1,673 | $95K |
| 87500 | <1% | 5,291 | $94K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 1,488 | $50K |
| 87640 | <1% | 2,766 | $27K | |
| 87481 | <1% | 1,543 | $24K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,170 | $23K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 17,512 | $21K |
| 87529 | <1% | 474 | $20K | |
| 87653 | <1% | 1,198 | $14K | |
| 87511 | <1% | 478 | $10K | |
| 99051 | <1% | 728 | $9K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 478 | $8K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 11,772 | $7K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 492 | $7K |
| 81003 | <1% | 3,016 | $6K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 128 | $5K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 464 | $3K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,200 | $2K |
| 99305 | <1% | 30 | $806.40 | |
| 99201 | <1% | 44 | $756.00 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 811 | $677.20 |
| 82962 | <1% | 391 | $620.44 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 106 | $562.76 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 23 | $557.60 |
| 74018 | <1% | 35 | $454.61 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 78 | $420.00 |
| 74019 | <1% | 21 | $299.46 | |
| 93000 | <1% | 39 | $201.60 | |
| 87807 | <1% | 13 | $112.10 | |
| 94760 | <1% | 268 | $88.96 | |
| 81025 | <1% | 16 | $32.60 | |
| 96127 | <1% | 27 | $2.61 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 18 | $0.00 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 64 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJUNKINS, JASON (OWNER)